| Proteoglycans: structures and interactions L Kjellén, U Lindahl Annual review of biochemistry 60 (1), 443-475, 1991 | 2567 | 1991 |
| Molecular diversity of heparan sulfate JD Esko, U Lindahl The Journal of clinical investigation 108 (2), 169-173, 2001 | 1162 | 2001 |
| Glycosaminoglycans and their binding to biological macromolecules U Lindahl, M Hook Annual review of biochemistry 47 (1), 385-417, 1978 | 1130 | 1978 |
| Regulated diversity of heparan sulfate U Lindahl, M Kusche-Gullberg, L Kjellén Journal of Biological Chemistry 273 (39), 24979-24982, 1998 | 870 | 1998 |
| Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. S Guimond, M Maccarana, BB Olwin, U Lindahl, AC Rapraeger Journal of Biological Chemistry 268 (32), 23906-23914, 1993 | 728 | 1993 |
| Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. U Lindahl, G Bäckström, L Thunberg, IG Leder Proceedings of the National Academy of Sciences 77 (11), 6551-6555, 1980 | 704 | 1980 |
| Mechanism of the anticoagulant action of heparin I Björk, U Lindahl Molecular and cellular biochemistry 48, 161-182, 1982 | 672 | 1982 |
| Glycosaminoglycans and the regulation of blood coagulation. MC Bourin, U Lindahl Biochemical Journal 289 (Pt 2), 313, 1993 | 618 | 1993 |
| Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. M Maccarana, B Casu, U Lindahl Journal of Biological Chemistry 268 (32), 23898-23905, 1993 | 604 | 1993 |
| Interactions between heparan sulfate and proteins: the concept of specificity J Kreuger, D Spillmann, J Li, U Lindahl The Journal of cell biology 174 (3), 323, 2006 | 596 | 2006 |
| Proteoglycans and sulfated glycosaminoglycans JD Esko, K Kimata, U Lindahl Essentials of Glycobiology. 2nd edition, 2009 | 587 | 2009 |
| Heparan sulfate: a piece of information M Salmivirta, K Lidholt, ULF Lindahl The FASEB journal 10 (11), 1270-1279, 1996 | 584 | 1996 |
| Further characterization of the antithrombin-binding sequence in heparin L Thunberg, G Bäckström, U Lindahl Carbohydrate research 100 (1), 393-410, 1982 | 574 | 1982 |
| Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin M Hook, I Bjork, J Hopwood, U Lindahl Febs Lett 66 (1), 90-93, 1976 | 545 | 1976 |
| The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate T Lind, F Tufaro, C McCormick, U Lindahl, K Lidholt Journal of Biological Chemistry 273 (41), 26265-26268, 1998 | 529 | 1998 |
| Structure of the antithrombin-binding site in heparin. U Lindahl, G Bäckström, M Höök, L Thunberg, LA Fransson, A Linker Proceedings of the National Academy of Sciences 76 (7), 3198-3202, 1979 | 512 | 1979 |
| QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling X Ai, AT Do, O Lozynska, M Kusche-Gullberg, U Lindahl, CP Emerson Jr The Journal of cell biology 162 (2), 341-351, 2003 | 501 | 2003 |
| Structure and biological interactions of heparin and heparan sulfate B Casu, U Lindahl Academic Press 57, 159-206, 2001 | 489 | 2001 |
| Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4 DA Lane, J Denton, AM Flynn, L Thunberg, U Lindahl Biochemical Journal 218 (3), 725-732, 1984 | 470 | 1984 |
| More to “heparin” than anticoagulation U Lindahl, K Lidholt, D Spillmann, L Kjellén Thrombosis research 75 (1), 1-32, 1994 | 460 | 1994 |
